Catalyst
Slingshot members are tracking this event:
Allergan's (AGN) Juvederm Vollure XC Approved by FDA for the Correction of Moderate-to-Severe Facial Wrinkles and Folds
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
AGN |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 20, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Juvederm, Vollure Xc, Fda, Approval, Correction, Moderate-to-severe, Facial Wrinkles, Folds